These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 28620195

  • 1. Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg.
    Wang Y, Lai P, Chen X, He C, Huang X, Geng S, Luo C, Wu S, Ling W, Zhong L, Lu Z, Li P, Weng J, Du X.
    Sci Rep; 2017 Jun 15; 7(1):3603. PubMed ID: 28620195
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG, Shevach EM, An F, Lin F, Medof ME.
    Nat Immunol; 2013 Feb 15; 14(2):162-71. PubMed ID: 23263555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
    Vadrevu SK, Chintala NK, Sharma SK, Sharma P, Cleveland C, Riediger L, Manne S, Fairlie DP, Gorczyca W, Almanza O, Karbowniczek M, Markiewski MM.
    Cancer Res; 2014 Jul 01; 74(13):3454-65. PubMed ID: 24786787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Emerging role of C5a/C5aR IL-17A axis in cGVHD.
    Chen X, Lai P, Wang Y, He C, Wu S, Huang X, Geng S, Luo C, Ling W, Zeng L, Li P, Jiang Z, Weng J, Du X.
    Am J Transl Res; 2018 Jul 01; 10(7):2148-2157. PubMed ID: 30093951
    [Abstract] [Full Text] [Related]

  • 8. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY, Zhang KQ.
    Int Urol Nephrol; 2018 Aug 01; 50(8):1545-1553. PubMed ID: 29594894
    [Abstract] [Full Text] [Related]

  • 9. Role of C5a-C5aR interaction in sepsis.
    Guo RF, Riedemann NC, Ward PA.
    Shock; 2004 Jan 01; 21(1):1-7. PubMed ID: 14676676
    [Abstract] [Full Text] [Related]

  • 10. C5a/C5aR pathway accelerates renal ischemia-reperfusion injury by downregulating PGRN expression.
    Zhang K, Li GQ, He QH, Li Y, Tang M, Zheng QY, Xu GL, Zhang KQ.
    Int Immunopharmacol; 2017 Dec 01; 53():17-23. PubMed ID: 29031143
    [Abstract] [Full Text] [Related]

  • 11. Immunization with a combination of 2 peptides derived from the C5a receptor significantly reduces early atherosclerotic lesion in Ldlr(tm1Her) Apob(tm2Sgy) J mice.
    Lu X, Xia M, Endresz V, Faludi I, Mundkur L, Gonczol E, Chen D, Kakkar VV.
    Arterioscler Thromb Vasc Biol; 2012 Oct 01; 32(10):2358-71. PubMed ID: 22837469
    [Abstract] [Full Text] [Related]

  • 12. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Hu Y, Cui Q, Ye Y, Luo Y, Tan Y, Shi J, Huang H.
    Hematol Oncol; 2017 Mar 01; 35(1):118-124. PubMed ID: 26439896
    [Abstract] [Full Text] [Related]

  • 13. C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage.
    Yuan B, Fu F, Huang S, Lin C, Yang G, Ma K, Shi H, Yang Z.
    Mol Neurobiol; 2017 Oct 01; 54(8):6187-6197. PubMed ID: 27709492
    [Abstract] [Full Text] [Related]

  • 14. C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1/2 signaling pathway.
    Liu Y, Xu SQ, Long WJ, Zhang XY, Lu HL.
    Eur Rev Med Pharmacol Sci; 2018 Nov 01; 22(22):7994-8003. PubMed ID: 30536348
    [Abstract] [Full Text] [Related]

  • 15. Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV.
    Jiang Y, Zhao G, Song N, Li P, Chen Y, Guo Y, Li J, Du L, Jiang S, Guo R, Sun S, Zhou Y.
    Emerg Microbes Infect; 2018 Apr 24; 7(1):77. PubMed ID: 29691378
    [Abstract] [Full Text] [Related]

  • 16. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
    Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP.
    Rheumatology (Oxford); 2007 Dec 24; 46(12):1773-8. PubMed ID: 17965442
    [Abstract] [Full Text] [Related]

  • 17. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH, Ruan CC, Ge Q, Ma Y, Xu JZ, Zhang ZB, Lin JR, Chen DR, Zhu DL, Gao PJ.
    Circ Res; 2018 Mar 30; 122(7):970-983. PubMed ID: 29437833
    [Abstract] [Full Text] [Related]

  • 18. C5a/C5aR pathway is essential for the pathogenesis of murine viral fulminant hepatitis by way of potentiating Fgl2/fibroleukin expression.
    Xu GL, Chen J, Yang F, Li GQ, Zheng LX, Wu YZ.
    Hepatology; 2014 Jul 30; 60(1):114-24. PubMed ID: 24604562
    [Abstract] [Full Text] [Related]

  • 19. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
    Hornum L, Hansen AJ, Tornehave D, Fjording MS, Colmenero P, Wätjen IF, Søe Nielsen NH, Bliddal H, Bartels EM.
    PLoS One; 2017 Jul 30; 12(12):e0189017. PubMed ID: 29220376
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).
    Nitta H, Wada Y, Kawano Y, Murakami Y, Irie A, Taniguchi K, Kikuchi K, Yamada G, Suzuki K, Honda J, Wilson-Morifuji M, Araki N, Eto M, Baba H, Imamura T.
    Clin Cancer Res; 2013 Apr 15; 19(8):2004-13. PubMed ID: 23287562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.